Author:
Serag H,Banerjee S,Saeb-Parsy K,Irving S,Wright K,Stearn S,Doble A,Gnanapragasam V J
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Allgar VL, Neal RD, Ali N, Leese B, Heywood P, Proctor G, Evans J (2006) Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer. Br J Gen Pract 56: 355–362
2. Andriole GL, Crawford ED, Grubb III RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O’Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360: 1310–1319
3. Debnath D, Dielehner N, Gunning KA (2002) Guidelines, compliance, and effectiveness: a 12 months’ audit in an acute district general healthcare trust on the two week rule for suspected colorectal cancer. Postgrad Med J 78: 748–751
4. Department of Health. The NHS Cancer Plan. Department of Health: London, 2000
5. Hawary AM, Warburton HE, Brough RJ, Collins GN, Brown SC, O’Reilly PH, Adeyoju AA (2008) The ‘2-week wait’ rule for referrals for suspected urological cancers--urgent need for refinement of criteria. Ann R Coll Surg Engl 90: 517–522